Congratulations to Ran Poliakine!
The largest-ever IPO of an early stage Israeli medical technology company was completed at a company valuation of $800 million!
Israeli medical imaging company Nanox has raised $165.2 million in a Nasdaq IPO, upsized by 28%, at a company valuation of $800 million. This is the largest ever initial public offering by an early stage Israeli medical technology company, which has yet to earn significant revenue, and has yet to receive FDA marketing approval for its lightweight mobile CT scanners. Based in Neve Ilan near Jerusalem, the company has begun trading under the NNOX ticker.
Nanox has developed a system combining digital X-ray device Nanox.ARC and an AI cloud-based software Nanox.CLOUD. The Nanox.ARC weighs 200 kilograms (compared to 2000 kilogram CT scanners) and is produced at a fraction of the cost ($10,000 versus a few millions for a regular CT scanner). Nanox‘s unique medical screening as a service (MSaaS) business model allows wide distribution and accessibility, and will charge health providers with a pay-per-scan service model. The company was founded in 2012 by CEO Ran Poliakine.
The company issued 9,178,744 ordinary shares at $18 per share, for gross proceeds of $165.2 million. In addition, Nanox has granted the underwriters a 30-day option to purchase up to an additional 1,376,812 ordinary shares at the IPO price, less underwriting discounts and commissions.
Cantor Fitzgerald & Co., Oppenheimer & Co. Inc., Berenberg and CIBC Capital Markets acted as joint book-runners and National Securities Corporation acted as co-manager for the offering.
The company raised $137 million before the IPO from investors including Korea’s SK Telecom, Industrial Alliance, Yozma Korea, Foxconn, Fuji, and Jin Ji Full.
Nanox, founded in 2012 by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Ran Poliakine founded Powermat, the company that pioneered wireless charging. Nanox’s novel technology will significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.
About JLM- BioCity
News on the many life science and healthcare companies in the Jerusalem area can be seen at https://jlm-biocity.org/jlm-biocity-innovations/
JLM-BioCity is a non-profit organization focused on developing and excelling Jerusalem’s bio-community.
We invite you, researcher, professional, investor and executive to become part of our vision, in building Jerusalem’s Biomed eco-system.
If you want your Company featured in our blogs , news releases, please contact: info at jlm-biocity.org